After 30 months of fast-paced innovation in quantum algorithms, six research groups are hoping to hit paydirt. But there can be only one big winner—if there is a winner at all.

A new synthesis finds that common epilepsies are driven by thousands of tiny-effect genetic variants, most still ...

AI is only as good as the data it learns from. Right now, research suggests 73% of health data in AI comes from North America ...

Politicians aren’t the best judges of the merits of scientific research. Read more at straitstimes.com. Read more at ...

An insightful mini-review published in Genomic Psychiatry synthesizes the rapidly expanding landscape of molecular genetic research on common epilepsies, assembling evidence from genome-wide ...

Transforming a nation of 1.4 billion people into the world's leading R&D hub is a monumental task. But by liberating the minds of the next generation of Indian scientists at 11, 12, and 13 years old, ...

Discover how AI healthcare technology and machine learning diagnosis are transforming disease detection, improving accuracy, and reshaping patient care in today's evolving medical landscape.

A DGIST research team led by Prof. Yoo Wookyung (Department of Brain Sciences) and Prof. Kim Jin Hae (Department of New Biology) developed an innovative analytical technology in collaboration with a ...

Explore how proteomics transforms pharmaceutical R&D, from drug discovery to biomarker qualification and clinical development.

Researchers combined AI simulations with NMR data to capture fleeting structures of intrinsically disordered proteins, ...